The "Global Olaparib Market" size was valued at US$ 2.18 Billion in 2024 and is projected to reach US$ 3.86 Billion by 2030, at a CAGR of 10.0% during the forecast period 2024-2030.
"United States Olaparib Market" size was valued at US$ 987 Million in 2024 and is projected to reach US$ 1.72 Billion by 2030, at a CAGR of 9.7% during the forecast period 2024-2030.
Olaparib is an oral medication classified as a poly (ADP-ribose) polymerase (PARP) inhibitor, primarily used in the treatment of cancers with specific genetic mutations, such as BRCA1 or BRCA2. It is particularly effective in ovarian, breast, prostate, and pancreatic cancers that exhibit defects in DNA repair mechanisms. Here are key points about Olaparib:
-
Mechanism of Action:
- Olaparib works by inhibiting the PARP enzyme, which plays a critical role in DNA repair. By blocking PARP, cancer cells, particularly those with BRCA mutations, are unable to repair DNA damage and eventually die.
-
FDA Approval:
- Approved by the U.S. FDA for the treatment of advanced ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer in patients with BRCA mutations or other homologous recombination deficiencies (HRD).
-
Indications:
- Primarily used in patients with BRCA-mutated cancers. Indicated for maintenance therapy in ovarian cancer following a response to platinum-based chemotherapy and in advanced breast and prostate cancers.
-
Administration:
- Olaparib is taken orally, usually in tablet form, with the dose and duration determined based on the type of cancer and patient-specific factors.
-
Side Effects:
- Common side effects include fatigue, nausea, anemia, low white blood cell counts, and increased risk of infections. In rare cases, it can cause myelodysplastic syndrome or acute myeloid leukemia.
-
Targeted Therapy:
- Olaparib is part of the class of targeted therapies that focus on exploiting specific weaknesses in cancer cells, such as defective DNA repair, making it less toxic to normal cells compared to conventional chemotherapy.
-
Combination Therapy:
- Often used in combination with other treatments, such as chemotherapy or immunotherapy, to enhance its efficacy, especially in cancers resistant to single-agent therapies.
-
Clinical Trials and Research:
- Extensive ongoing research is being conducted to expand the use of Olaparib in other cancers and in combination with other drugs to target different pathways involved in cancer progression.
-
Companion Diagnostic:
- Genetic testing for BRCA mutations or other DNA repair defects is often required before initiating Olaparib therapy to identify patients most likely to benefit from the treatment.
Report Overview
This report provides a deep insight into the global Olaparib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Olaparib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Olaparib market in any manner.
Global Olaparib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- AstraZeneca
- Everest Pharmaceuticals
By Type
By Application
- Ovarian Cancers
- Breast Cancers
- Prostate Cancers
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Olaparib Market
- Overview of the regional outlook of the Olaparib Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Olaparib
1.2 Key Market Segments
1.2.1 Olaparib Segment by Type
1.2.2 Olaparib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Olaparib Market Overview
2.1 Global Market Overview
2.1.1 Global Olaparib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Olaparib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Olaparib Market Competitive Landscape
3.1 Global Olaparib Sales by Manufacturers (2019-2024)
3.2 Global Olaparib Revenue Market Share by Manufacturers (2019-2024)
3.3 Olaparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Olaparib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Olaparib Sales Sites, Area Served, Product Type
3.6 Olaparib Market Competitive Situation and Trends
3.6.1 Olaparib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Olaparib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Olaparib Industry Chain Analysis
4.1 Olaparib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Olaparib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Olaparib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Olaparib Sales Market Share by Type (2019-2024)
6.3 Global Olaparib Market Size Market Share by Type (2019-2024)
6.4 Global Olaparib Price by Type (2019-2024)
7 Olaparib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Olaparib Market Sales by Application (2019-2024)
7.3 Global Olaparib Market Size (M USD) by Application (2019-2024)
7.4 Global Olaparib Sales Growth Rate by Application (2019-2024)
8 Olaparib Market Segmentation by Region
8.1 Global Olaparib Sales by Region
8.1.1 Global Olaparib Sales by Region
8.1.2 Global Olaparib Sales Market Share by Region
8.2 North America
8.2.1 North America Olaparib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Olaparib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Olaparib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Olaparib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Olaparib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca Olaparib Basic Information
9.1.2 AstraZeneca Olaparib Product Overview
9.1.3 AstraZeneca Olaparib Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Olaparib SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 Everest Pharmaceuticals
9.2.1 Everest Pharmaceuticals Olaparib Basic Information
9.2.2 Everest Pharmaceuticals Olaparib Product Overview
9.2.3 Everest Pharmaceuticals Olaparib Product Market Performance
9.2.4 Everest Pharmaceuticals Business Overview
9.2.5 Everest Pharmaceuticals Olaparib SWOT Analysis
9.2.6 Everest Pharmaceuticals Recent Developments
10 Olaparib Market Forecast by Region
10.1 Global Olaparib Market Size Forecast
10.2 Global Olaparib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Olaparib Market Size Forecast by Country
10.2.3 Asia Pacific Olaparib Market Size Forecast by Region
10.2.4 South America Olaparib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Olaparib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Olaparib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Olaparib by Type (2025-2030)
11.1.2 Global Olaparib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Olaparib by Type (2025-2030)
11.2 Global Olaparib Market Forecast by Application (2025-2030)
11.2.1 Global Olaparib Sales (Kilotons) Forecast by Application
11.2.2 Global Olaparib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Olaparib Market Size Comparison by Region (M USD)
Table 5. Global Olaparib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Olaparib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Olaparib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Olaparib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Olaparib as of 2022)
Table 10. Global Market Olaparib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Olaparib Sales Sites and Area Served
Table 12. Manufacturers Olaparib Product Type
Table 13. Global Olaparib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Olaparib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Olaparib Market Challenges
Table 22. Global Olaparib Sales by Type (Kilotons)
Table 23. Global Olaparib Market Size by Type (M USD)
Table 24. Global Olaparib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Olaparib Sales Market Share by Type (2019-2024)
Table 26. Global Olaparib Market Size (M USD) by Type (2019-2024)
Table 27. Global Olaparib Market Size Share by Type (2019-2024)
Table 28. Global Olaparib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Olaparib Sales (Kilotons) by Application
Table 30. Global Olaparib Market Size by Application
Table 31. Global Olaparib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Olaparib Sales Market Share by Application (2019-2024)
Table 33. Global Olaparib Sales by Application (2019-2024) & (M USD)
Table 34. Global Olaparib Market Share by Application (2019-2024)
Table 35. Global Olaparib Sales Growth Rate by Application (2019-2024)
Table 36. Global Olaparib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Olaparib Sales Market Share by Region (2019-2024)
Table 38. North America Olaparib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Olaparib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Olaparib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Olaparib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Olaparib Sales by Region (2019-2024) & (Kilotons)
Table 43. AstraZeneca Olaparib Basic Information
Table 44. AstraZeneca Olaparib Product Overview
Table 45. AstraZeneca Olaparib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AstraZeneca Business Overview
Table 47. AstraZeneca Olaparib SWOT Analysis
Table 48. AstraZeneca Recent Developments
Table 49. Everest Pharmaceuticals Olaparib Basic Information
Table 50. Everest Pharmaceuticals Olaparib Product Overview
Table 51. Everest Pharmaceuticals Olaparib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Everest Pharmaceuticals Business Overview
Table 53. Everest Pharmaceuticals Olaparib SWOT Analysis
Table 54. Everest Pharmaceuticals Recent Developments
Table 55. Global Olaparib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Global Olaparib Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America Olaparib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. North America Olaparib Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe Olaparib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 60. Europe Olaparib Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific Olaparib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 62. Asia Pacific Olaparib Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America Olaparib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 64. South America Olaparib Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa Olaparib Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa Olaparib Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global Olaparib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 68. Global Olaparib Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global Olaparib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 70. Global Olaparib Sales (Kilotons) Forecast by Application (2025-2030)
Table 71. Global Olaparib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Olaparib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Olaparib Market Size (M USD), 2019-2030
Figure 5. Global Olaparib Market Size (M USD) (2019-2030)
Figure 6. Global Olaparib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Olaparib Market Size by Country (M USD)
Figure 11. Olaparib Sales Share by Manufacturers in 2023
Figure 12. Global Olaparib Revenue Share by Manufacturers in 2023
Figure 13. Olaparib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Olaparib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Olaparib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Olaparib Market Share by Type
Figure 18. Sales Market Share of Olaparib by Type (2019-2024)
Figure 19. Sales Market Share of Olaparib by Type in 2023
Figure 20. Market Size Share of Olaparib by Type (2019-2024)
Figure 21. Market Size Market Share of Olaparib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Olaparib Market Share by Application
Figure 24. Global Olaparib Sales Market Share by Application (2019-2024)
Figure 25. Global Olaparib Sales Market Share by Application in 2023
Figure 26. Global Olaparib Market Share by Application (2019-2024)
Figure 27. Global Olaparib Market Share by Application in 2023
Figure 28. Global Olaparib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Olaparib Sales Market Share by Region (2019-2024)
Figure 30. North America Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Olaparib Sales Market Share by Country in 2023
Figure 32. U.S. Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Olaparib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Olaparib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Olaparib Sales Market Share by Country in 2023
Figure 37. Germany Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Olaparib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Olaparib Sales Market Share by Region in 2023
Figure 44. China Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Olaparib Sales and Growth Rate (Kilotons)
Figure 50. South America Olaparib Sales Market Share by Country in 2023
Figure 51. Brazil Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Olaparib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Olaparib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Olaparib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Olaparib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Olaparib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Olaparib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Olaparib Market Share Forecast by Type (2025-2030)
Figure 65. Global Olaparib Sales Forecast by Application (2025-2030)
Figure 66. Global Olaparib Market Share Forecast by Application (2025-2030)
